Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:Q15744 (
C/EBP epsilon
)
82
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Neutrophils from CCAAT enhancer binding protein epsilon (
C/EBP epsilon
) knockout mice have morphological and biochemical features similar to those observed in patients with an extremely rare congenital disorder called neutrophil-specific secondary granule deficiency (SGD). SGD is characterized by frequent bacterial infections attributed, in part, to the lack of neutrophil secondary granule proteins (SGP). A mutation that results in loss of functional
C/EBP epsilon
activity has recently been described in an SGD patient, and has been postulated to be the cause of the disease in this patient. We have previously demonstrated that overexpression of CCAAT displacement protein (
CDP
/cut), a highly conserved transcriptional repressor of developmentally regulated genes, suppresses expression of SGP genes in 32Dcl3 cells. This phenotype resembles that observed in both
C/EBP epsilon
(-/-) mice and in SGD patients. Based on these observations we investigated potential interactions between
C/EBP epsilon
and
CDP
/cut during neutrophil maturation. In this study, we demonstrate that inducible expression of
C/EBP epsilon
in 32Dcl3/tet cells results in granulocytic differentiation. Furthermore, Northern blot analysis of G-CSF-induced
CDP
/cut overexpressing 32Dcl3 cells revealed absence of
C/EBP epsilon
mRNA. We therefore hypothesize that
C/EBP epsilon
positively regulates SGP gene expression, and that
C/EBP epsilon
is itself negatively regulated by
CDP
/cut during neutrophil maturation. We further demonstrate that the
C/EBP epsilon
promoter is regulated by
CDP
/cut during myeloid differentiation.
...
PMID:C/EBP epsilon mediates myeloid differentiation and is regulated by the CCAAT displacement protein (CDP/cut). 1143 45
In vitro models of granulopoiesis involving the inducible expression of either CCAAT enhancer binding protein alpha (C/EBP alpha) or
C/EBP epsilon
in myeloid cells have been shown to lead to the induction of a granulocytic maturation program accompanied by the expression of myeloid-specific genes. Since members of the C/EBP family of transcription factors recognize and bind to similar DNA-binding motifs, it has been difficult to elucidate the specific role of each of the C/EBP family members in eliciting myeloid gene expression. In order to address this issue, we focused on the expression of the lactoferrin (LF) gene. LF expression is transcriptionally regulated in a C/EBP-dependent manner in myeloid cells. Using chromatin immunoprecipitation (ChIP) analysis we demonstrate that C/EBP alpha binds to the LF promoter in nonexpressing cells. Upon induction of maturation,
C/EBP epsilon
binds to the LF promoter, which correlates with LF expression. Lack of LF expression in the acute promyelocytic leukemia cell line NB4, which harbors the t(15;17) translocation, cannot be correlated with aberrant binding at the C/EBP site in the LF promoter. It is, however, associated with the persistent binding of the silencer CCAAT displacement protein (
CDP
/cut) to the LF promoter in these cells. We conclude that C/EBP alpha,
C/EBP epsilon
, and
CDP
/cut all play definitive roles in regulating late gene expression during normal myeloid development.
...
PMID:Chromatin immunoprecipitation (ChIP) studies indicate a role for CCAAT enhancer binding proteins alpha and epsilon (C/EBP alpha and C/EBP epsilon ) and CDP/cut in myeloid maturation-induced lactoferrin gene expression. 1252